A Phase III, Randomized, Double-blind, Active-controlled, Parallel Group, Multi-center Trial Assessing the Efficacy and Safety of a Once-Weekly and Once-Monthly, Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Treatment of Adult Ou

Grants and Contracts Details

StatusFinished
Effective start/end date1/7/16 → 7/31/17

Funding

  • Medpace Inc: $111,495.00